Carderock Capital Management Inc. trimmed its holdings in AMETEK, Inc. (NYSE:AME - Free Report) by 5.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 45,102 shares of the technology company's stock after selling 2,596 shares during the quarter. AMETEK makes up about 2.0% of Carderock Capital Management Inc.'s holdings, making the stock its 22nd biggest position. Carderock Capital Management Inc.'s holdings in AMETEK were worth $8,130,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Itau Unibanco Holding S.A. raised its stake in shares of AMETEK by 62.6% during the third quarter. Itau Unibanco Holding S.A. now owns 200 shares of the technology company's stock worth $34,000 after purchasing an additional 77 shares during the last quarter. Versant Capital Management Inc increased its stake in AMETEK by 3,116.7% in the 4th quarter. Versant Capital Management Inc now owns 193 shares of the technology company's stock valued at $35,000 after buying an additional 187 shares during the period. AdvisorNet Financial Inc raised its position in AMETEK by 1,176.5% during the 4th quarter. AdvisorNet Financial Inc now owns 217 shares of the technology company's stock worth $39,000 after buying an additional 200 shares during the last quarter. Princeton Global Asset Management LLC acquired a new stake in shares of AMETEK in the 3rd quarter worth $44,000. Finally, Anchor Investment Management LLC boosted its holdings in shares of AMETEK by 366.1% in the third quarter. Anchor Investment Management LLC now owns 261 shares of the technology company's stock valued at $45,000 after acquiring an additional 205 shares in the last quarter. Hedge funds and other institutional investors own 87.43% of the company's stock.
Wall Street Analysts Forecast Growth
AME has been the subject of several analyst reports. Robert W. Baird increased their price target on shares of AMETEK from $166.00 to $186.00 and gave the stock a "neutral" rating in a report on Monday, November 4th. StockNews.com downgraded AMETEK from a "buy" rating to a "hold" rating in a research note on Friday. TD Cowen downgraded AMETEK from a "hold" rating to a "sell" rating in a research note on Monday, October 7th. Mizuho increased their price objective on AMETEK from $190.00 to $200.00 and gave the stock an "outperform" rating in a research report on Friday, November 1st. Finally, Truist Financial raised their target price on AMETEK from $221.00 to $222.00 and gave the company a "buy" rating in a report on Thursday. One analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $203.44.
Check Out Our Latest Stock Analysis on AMETEK
Insider Activity at AMETEK
In other AMETEK news, insider Tony J. Ciampitti sold 16,210 shares of the business's stock in a transaction on Friday, November 22nd. The stock was sold at an average price of $197.01, for a total value of $3,193,532.10. Following the completion of the transaction, the insider now directly owns 49,490 shares in the company, valued at approximately $9,750,024.90. The trade was a 24.67 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Emanuela Speranza sold 6,747 shares of the firm's stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $195.90, for a total value of $1,321,737.30. Following the sale, the insider now owns 30,460 shares in the company, valued at $5,967,114. This trade represents a 18.13 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 29,200 shares of company stock valued at $5,707,620 over the last quarter. Insiders own 0.61% of the company's stock.
AMETEK Price Performance
NYSE:AME traded down $0.12 during mid-day trading on Friday, hitting $180.74. 2,612,857 shares of the company's stock traded hands, compared to its average volume of 778,650. The company has a debt-to-equity ratio of 0.18, a quick ratio of 0.84 and a current ratio of 1.39. The company has a market cap of $41.81 billion, a PE ratio of 31.49, a price-to-earnings-growth ratio of 2.51 and a beta of 1.16. The firm's 50 day simple moving average is $187.17 and its 200 day simple moving average is $175.12. AMETEK, Inc. has a 1 year low of $149.03 and a 1 year high of $198.33.
AMETEK (NYSE:AME - Get Free Report) last issued its quarterly earnings data on Thursday, October 31st. The technology company reported $1.66 earnings per share for the quarter, topping analysts' consensus estimates of $1.62 by $0.04. AMETEK had a net margin of 19.27% and a return on equity of 16.88%. The business had revenue of $1.71 billion during the quarter, compared to analysts' expectations of $1.71 billion. During the same period last year, the company posted $1.64 EPS. The company's revenue was up 5.3% on a year-over-year basis. Sell-side analysts expect that AMETEK, Inc. will post 6.8 EPS for the current year.
AMETEK Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, December 20th. Stockholders of record on Friday, December 6th were given a $0.28 dividend. The ex-dividend date was Friday, December 6th. This represents a $1.12 annualized dividend and a dividend yield of 0.62%. AMETEK's dividend payout ratio is currently 19.51%.
AMETEK Profile
(
Free Report)
AMETEK, Inc manufactures and sells electronic instruments and electromechanical devices in the North America, Europe, Asia, and South America, and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and c devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and sensors for gas turbines and dashboard instruments; heavy trucks, instrumentation, and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry.
Recommended Stories
Before you consider AMETEK, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and AMETEK wasn't on the list.
While AMETEK currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report